Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Moodys
Dow
Merck
Harvard Business School

Last Updated: June 4, 2023

Competitive Generic Therapies: Off-Patent Drugs With 1-4 Sources


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


This table lists drugs which, despite having no patents or regulatory protections, have a limited number of active sources.

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Strength
Lupin Ltd ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE abacavir sulfate; lamivudine; zidovudine TABLET;ORAL 202912-001 Dec 5, 2013 AB RX No No EQ 300MG BASE;150MG;300MG
Viiv Hlthcare TRIZIVIR abacavir sulfate; lamivudine; zidovudine TABLET;ORAL 021205-001 Nov 14, 2000 AB RX Yes Yes EQ 300MG BASE;150MG;300MG
Glenmark Generics ACAMPROSATE CALCIUM acamprosate calcium TABLET, DELAYED RELEASE;ORAL 202229-001 Jul 16, 2013 AB RX No Yes 333MG
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Strength

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Boehringer Ingelheim
Medtronic
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.